Clinical Trial

Creatine for Depressed Male and Female Methamphetamine Users

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated December 11, 2015 (before its estimated October 2016 completion). Its status may not reflect the trial's current state.
Summary
* Assess the antidepressant/anxiolytic effect of creatine in male and female methamphetamine users * Assess creatine's effect on methamphetamine use * Assess the safety of creatine in male methamphetamine users with depression
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2015-10-02; most recent amendment 2025-10-09.
Status change: Recruiting → Completed 2024-02-12
Status change: Not Yet Recruiting → Recruiting 2015-12-10
Trial Details
NCT Number NCT02568878
Lead Sponsor Montana State University
Conditions Depression, Anxiety, Methamphetamine Dependence
Enrollment 29 participants
Start Date 2015-11
Primary Completion 2016-10 (estimated)
Study Completion 2017-05 (estimated)
Updated on ClinicalTrials.gov 2015-12-11